The Metropolitan City of Milan and the broader Lombardy region represent the absolute epicenter of Europe’s pharmaceutical, CDMO (Contract Development and Manufacturing Organization), and high-end nutraceutical manufacturing network. Accounting for over 32% of Italy’s total pharmaceutical production output and housing critical R&D centers across Monza, Agrate Brianza, and Milan’s biotech corridors, local market leaders demand unparalleled mechanical integrity, strict disintegration control, and seamless compliance with European Medicines Agency (EMA) standards.
As a global contract research, formulation, and specialized tablet compression manufacturing authority operating across 60+ countries with 38+ years of technical heritage, our engineered solid dosage solutions bridge the gap between high-capacity manufacturing economics and precision European regulatory compliance. From multi-layer compression matrices to advanced liposomal bioavailability retention and high-speed automated analytical testing, we supply Milanese brand owners and pharmaceutical procurement directors with audit-ready, high-performance tableting platforms.
Engineered for the stringent quality parameters of Milanese pharmaceutical hubs, healthcare brands, and cosmetic skin care pioneers.
Designed for real-time IPC (In-Process Control) in high-speed tableting suites. Features a 200N load cell, intuitive HMI touch interface, and precise measurement of tablet breaking force to ensure compliance with European Pharmacopoeia (Ph. Eur.) guidelines.
Contact Us
Utilizes direct-compression lipid encapsulation techniques to safeguard ascorbic acid from gastric degradation. Tailored for Milan’s premium pharmacy D2C market with enhanced cellular uptake dynamics.
Contact Us
Engineered using standardized botanical actives with optimized binder-to-active ratios, preventing capping and lamination during high-tonnage rotary compression runs.
Contact Us
Versatile 500mg solid dosage form utilizing high-compressibility microcrystalline cellulose (MCC) vectors. Fully customizable shape, scoring, and film-coating for European distribution.
Contact Us
Ultra-compacted hydraulic matrix designed for swift fluid absorption and expansion upon hydration. Ideal for Milan's renowned luxury cosmetics and salon treatment supply chains.
Contact Us
Advanced analytical testing system providing automated speed adjustments, multi-parameter hardness profiles, and real-time digital printouts for QA validation in GMP facilities.
Contact Us
Multi-mineral high-density compression matrix optimized to prevent friability while ensuring rapid disintegration. Exported in thermoform ALU-ALU or PVC/PVDC blister configurations.
Contact Us
Formulated with moisture-controlled phytocompounds designed for stability in challenging climatic conditions. Fully tailored private-label manufacturing with custom branding.
Contact UsThe operational demands of tablet manufacturing in Northern Italy require dynamic adaptability across multiple regulated sectors. Rather than offering one-size-fits-all manufacturing, our facility operates dedicated, environmentally controlled production blocks (air-handled Class 100,000 cleanrooms with regulated RH below 30% for moisture-sensitive actives) tailored to specific local applications:
Supporting Lombardy’s contract pharmaceutical developers with precise clinical-to-commercial scale-up. We conduct Heckel plot analysis and force-displacement evaluations to determine optimal dwelling time and pre-compression pressures, eliminating micro-capping in high-speed rotary presses.
Milan is home to groundbreaking health-tech and direct-to-consumer supplement brands demanding innovative delivery vehicles. We manufacture chewable effervescent tablets, modified-release caplets, and liposomal matrices that align with EFSA (European Food Safety Authority) health claims.
Matching the aesthetic and functional standards of Milan’s global beauty sector. Our dry-compression processes create zero-binder facial mask tablets and water-activated solid skin cleansers, offering carbon-neutral shipping footprints for eco-conscious luxury brands.
As the European Union accelerates its transitions under the EU Green Deal and stringent EMA Good Manufacturing Practice updates, tablet compression technology is undergoing rapid evolution. Procurement teams in Milan are increasingly moving away from traditional wet granulation setups toward energy-efficient direct compression and high-tech quality verification.
To reduce energy consumption and preserve thermal integrity of sensitive actives (such as probiotics, enzymes, and botanical extracts), our R&D center utilizes engineered spray-dried co-processed excipients. By optimizing particle size distribution (PSD) and bulk density, we achieve direct compression stability for over 65% of custom formulations, reducing batch lead times for Italian clients by up to 40%.
Modern pharmaceutical production in Italy demands continuous quality monitoring. By integrating automated testing instrumentation—such as the Cell Instruments MPT-01 and high-precision digital hardness testers—tableting lines dynamically adjust main compression forces based on real-time thickness and breaking force feeds. This zero-defect approach prevents batch rejections and ensures strict uniformity of mass (EP 2.9.5).
Following the EFSA ban on Titanium Dioxide (E171) as a food additive across the European Union, our coating suites have transitioned entirely to natural, opaque, TiO2-free film polymers (utilizing calcium carbonate, rice starch, and natural iron oxides). Italian brand owners can choose between aqueous clear, enteric gastro-resistant, or custom color-matched aesthetic coatings that comply fully with current EU regulations.
With over 38 years of specialized formulation experience, our state-of-the-art campus in Paonta Sahib (supported by corporate headquarters in Noida) delivers world-class CRAMS (Contract Research and Manufacturing Services) for international clients. Our technical superiority rests on four pillars of E-E-A-T (Experience, Expertise, Authoritativeness, and Trustworthiness):
Clear answers regarding compliance, lead times, custom tableting specifications, and shipping logistics to Northern Italy.
Every shipment sent to the Milan market includes a comprehensive compliance dossier: Batch Certificate of Analysis (CoA), GMP Certificate, FSSC 22000 accreditation, ISO compliance files, Allergen Statements, Non-GMO declarations, and BSE/TSE-free certificates. We also assist with EU label claim alignment under EFSA guidelines.
Yes. We engineer tooling (B-tooling, D-tooling, and multi-tip punch sets) to produce custom geometry: oval, caplet, round, pentagonal, break-scored, or embossed with your brand’s logo. Our tooling engineers perform compression stress analysis to prevent punch sticking or capping during production.
Moisture-sensitive active ingredients are processed in environmentally controlled suites where relative humidity is maintained below 30% RH. We offer specialized desiccant-integrated bottle packaging or high-barrier ALU-ALU blister foil laminates to guarantee active potency throughout shelf life.
Standard commercial batch MOQs begin at 100,000 to 300,000 tablets depending on formulation complexity and raw material sourcing. Initial prototype samples take 2–3 weeks, followed by commercial production and export transit to Milan within 4–6 weeks.
Yes, in addition to contract tablet manufacturing, we export advanced laboratory testing instrumentation—including the Cell Instruments MPT-01 Tablet Compression Tester. These systems come with IQ/OQ/PQ validation documentation and HMI touch interfaces suitable for inline quality control suites.
Partner with an established global contract manufacturer equipped with US FDA registration, FSSC 22000 standards, and 38+ years of formulation excellence. Contact our technical engineering desk today for pilot trial scheduling, OEM quotations, or custom tooling feasibility evaluations.
Contact Us
